Mining the gut microbiota, the trillion microbes living in our digestive system is a promising approach for developing new sensors providing a response to disease and abnormalities in the body. To date, these efforts have largely relied on fecal samples, however, to obtain an instantaneous snapshot of bacterial behavior inside the gut using these techniques, invasive sampling is required via colonoscopy or a biopsy.
Now, a study from researchers at Harvard University engineers synthetic bacterial memory circuits enabling microbial diagnostics for sensing biomolecules in the gut. The team states they have developed an effective, non-invasive way to quickly identify new bacterial biosensors which can recognize and report the presence of various disease triggers in the gut, helping set the stage for a new frontier of digestive health monitoring and treatment. The opensource study is published in the journal mSystems.
DNA computers monitor the body
Recent studies from the lab designed a genetic circuit consisting of a memory element derived from a virus and a synthetic trigger element capable of detecting and recording the presence of a deactivated version of the antibiotic tetracycline.
The synthetic circuit was integrated into the genomes of E. coli bacteria introduced into live mice consequently fed tetracycline. This caused the trigger in the bacterial circuit to activate the memory element that remained on for a week, however, this was just one molecule with real-world diagnostics rapidly testing multiple disease signals. The current study updates the past circuit to sense a variety of molecular signals.
The current study develops a library of different strains of E. coli, each containing synthetic memory circuitry and a unique trigger element in its genome; this library of bacterial strains was introduced into the guts of live mice.
Results show the memory elements were turned on during passage through the mice. Data findings show two of the strains, in particular, showed consistent activation, even when given to mice in isolation, indicating they were activated by conditions inside the mice’s gut and could serve as sensors of gut-specific signals.
An in vivo biocomputer monitor
The experiment was repeated using a smaller library of E. coli strains whose trigger elements were genetic sequences thought to be associated with inflammation, ten of which were activated during transit through the mice. The team states they have engineered a memory circuit for parallel, high-throughput screening of hundreds of potential triggers, and apply this method to identify new triggers responding specifically to the gut environment.
They go on to add through comparison between healthy mice and those suffering from inflammation, triggers responding differently during disease were also identified. They conclude these results provide a platform for in vivo noninvasive biosensor trigger discovery and longitudinal testing.
The team surmises they have engineered a synthetic bacterial memory as a biosensor trigger screening tool for gut microbiota. For the future, the researchers state their study is a step closer to engineering complex signaling pathways in bacteria which allow them to detect and even treat diseases long-term.
Don’t miss the latest discoveries from the health innovator community:
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.